Advertisement

Toxic shock syndrome associated with use of a nasal tampon

  • Ronald G. Nahass
    Correspondence
    Requests for reprints should be addressed to Dr. Ronald Nahass, Division of Infectious Disease, Department of Medicine, UMDNJ-RWJUH, One Robert Wood Johnson Place, CN 19, New Brunswick, New Jersey 08903-0019.
    Affiliations
    Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Search for articles by this author
  • David J. Gocke
    Affiliations
    Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Toxic shock syndrome has been noted to occur with nasal surgery, both with and without packing. A new synthetic sponge, described as a nasal tampon, has become available for use as packing after surgery. Herein is reported the first case of toxic shock syndrome associated with the use of this nasal tampon.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Todd JK
        • Fishaut M
        • Kapral F
        • Welch T
        Toxic shock syndrome associated with phage-group-1 staphylococci.
        Lancet. 1978; II: 1116-1118
        • Davis JP
        • Chesney PT
        • Wand PJ
        • La Venture M
        • et al.
        Toxic shock syndrome; epidemiologic features, recurrence, risk factors, and prevention.
        N Engl J Med. 1980; 303: 1429-1435
        • Centers for Disease Control
        Toxic-shock syndrome.
        MMWR. 1982; 31 (United States, 1970–1982): 201-204
        • Barbour SD
        • Shales DM
        • Guertin SR
        Toxic shock syndrome associated with nasal packing: analogy of tampon-associated illness.
        Pediatrics. 1984; 73: 163-165
        • Jacobson JA
        • Kaswam EM
        Toxic shock syndrome after nasal surgery.
        Arch Otolaryngol Head Neck Surg. 1986; 112: 329-332
        • Huang IT
        • Podkomorska D
        • Murphy MN
        • Hoffer I
        Toxic shock syndrome following septoplasty and partial turbinectomy.
        Otolaryngol. 1986; 15: 310-312
        • Wagner R
        • Toback J
        Toxic shock syndrome following septoplasty using plastic septal splints.
        Laryngoscope. 1986; 96: 609-610
        • Tierno PM
        • Jacobs JB
        • Lebowitz AS
        In vitro and in vivo study of Merocel nasal tampons with special emphasis on risk of toxic shock syndrome development.
        (abstr)in: Presented at the American Society of Microbiology Meeting, Atlanta1987
        • Reingold AL
        • Hargrett NT
        • Shands KN
        • et al.
        Toxic shock syndrome surveillance in the United States, 1980–1981.
        Ann Intern Med. 1982; 96: 875-880
        • Reingold AL
        • Hargrett NT
        • Dan BB
        • Shands KN
        • Strickland BY
        • Broome CV
        Monmenstrual toxic shock syndrome: a review of 130 cases.
        Ann Intern Med. 1982; 96: 871-874
        • Reingold AL
        • Dan BB
        • Shands KN
        • Broome CV
        Toxic-shock syndrome not associated with menstruation.
        Lancet. 1982; I: 1-4
        • Bartlett P
        • Reingold AL
        • Graham DR
        • et al.
        Toxic shock syndrome associated with surgical wound infections.
        JAMA. 1982; 247: 1448-1450
        • Thomas S
        Toxic shock syndrome following submucous resection and rhinoplasty.
        JAMA. 1982; 247: 2403-2404
        • Garpe PC
        • Arko RJ
        • Reingold AL
        • et al.
        Staphylococcus aureus isolates from patients with non-menstrual toxic shock syndrome.
        JAMA. 1985; 253: 2538-2542
        • Todd JK
        • Todd BH
        • Franco-Buff A
        • Smith CM
        • Lawellin DW
        Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
        J Infect Dis. 1987; 155: 673-681
        • Mills JT
        • Parsonnet J
        • Tsai YC
        • Kendrick M
        • Hickman RK
        • Kass EH
        Control of production of toxic shock syndrome toxin-1(TSST-1) by magnesium ion.
        J Infect Dis. 1985; 152: 618-620
        • Tierno PM
        • Hanna BA
        Magnesium and the production of toxic shock syndrome toxin-1 by Staphylococcus aureus.
        J Infect Dis. 1986; 153: 994-995